Opko和Allergan公司的药物的目标是阻止眼后泄露血管的形成促进基因的失活，该基因是严重黄斑变性的标志。
The Opko and Allergan drugs aim to inactivate a gene that contributes to the formation of leaky blood vessels in the back of the eye, the hallmark of the severe form of macular degeneration.
Opko和Allergan公司的药物的目标是阻止眼后泄露血管的形成促进基因的失活，该基因是严重黄斑变性的标志。
The Opko and Allergan drugs aim to inactivate a gene that contributes to the formation of leaky blood vessels in the back of the eye, the hallmark of the severe form of macular degeneration.
应用推荐